To compare the patient own blood product and suturing in terms of skin graft uptake and fixation of ulcer

To identify the effectiveness of Autologous Platelet Rich Plasma as compared to Mechanical fixation of Split Thickness Skin Graft in cutaneous ulcer - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061810

Enrollment

Registered

2024-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Autologous Platelet Rich Plasma: Autologous Platelet Rich Plasma is applied over the ulcer site before placing the skin graft over the ulcer site. Autologous platelet rich plasma will a

Eligibility

Inclusion criteria

Inclusion criteria: Maximum ulcer area of 100 sq cm Wagner’s classification grade 1 & 2

Exclusion criteria

Exclusion criteria: Patients with ß hemolytic streptococcus infection Patients who were positive for HIV, HBsAg and HCV Patients with coagulation disorders Malignant ulcer Monophasis PVD

Design outcomes

Secondary

Measure	Time frame
Hematoma formationTimepoint: this outcome will be assessed during postoperative period usually 10 days after the procedure	—

Primary

Measure	Time frame
To compare the uptake of skin graft between patients undergoing split skin graft with and without Platelet Rich PlasmaTimepoint: This data will be assessed during the post operative period especially during post operative day 3,5 and 7 split skin graft with and without Platelet Rich Plasma	—

Countries

India

Contacts

Public ContactDr Goutham P

Pondicherry Institute of Medical Sciences

ashwin.chand84@gmail.com8489006986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026